Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies

Neuromuscular Disorders

Volumn 15, Issue 1, 2005, Pages 32-39

  Teixeira, Antonio ^a,b   Cherin, Patrick ^b   Demoule, Alexandre ^b   Levy Soussan, Michèle ^b   Straus, Christian ^a,b   Verin, Eric ^a,c   Zelter, Marc ^a,b   Derenne, Jean Philippe ^a,b   Herson, Serge ^b   Similowski, Thomas ^a,b  

^a site Pitié Salpêtrière   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Dermatomyositis; Diaphragm; Inclusion body myositis; Magnetic stimulation; Phrenic stimulation; Polymyositis; Respiratory muscle; Sleep disordered breathing

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CONTROLLED STUDY; DIAPHRAGM MUSCLE; EXPIRATORY FLOW; FEMALE; HUMAN; IDIOPATHIC DISEASE; INSPIRATORY CAPACITY; INTERSTITIAL PNEUMONIA; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUTH BREATHING; MYOSITIS; NERVE STIMULATION; PHRENIC NERVE; PRIORITY JOURNAL; AGED; BREATHING; COMPARATIVE STUDY; DIAPHRAGM; DIAPHRAGM PARALYSIS; ELECTROSTIMULATION; LUNG FUNCTION TEST; METHODOLOGY; MIDDLE AGED; NERVE CONDUCTION; NEUROMUSCULAR DISEASE; NONPARAMETRIC TEST; PATHOPHYSIOLOGY;

AGED; DIAPHRAGM; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; NEURAL CONDUCTION; NEUROMUSCULAR DISEASES; PHRENIC NERVE; RESPIRATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY PARALYSIS; STATISTICS, NONPARAMETRIC;

EID: 20144375314     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2004.09.006     Document Type: Article

References (40)

1. Schwarz MI. The lung in polymyositis. Clin Chest Med 1998;19: 701-12 viii.
2. Marie I, Hatron PY, Hachulla E, et al. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998;25:1336-43.
3. Remmers JE. Sleeping and breathing. Chest 1990;97:77S-880.
4. Arnulf I, Similowski T, Salachas F, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2000;161:849-56.
5. Similowski T, Attali V, Bensimon G, et al. Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J 2000; 15:332-7.
6. Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127:450-3.
7. Borasio CD, Gelinas DF, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol 1998;245:S7.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
9. Sayers ME, Chou SM, Calabrese LH. Inclusion body myositis: analysis of 32 cases. J Rheumatol 1992;19:1385-9.
10. Cherin P, Pelletier S, Teixeira A, et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 2002;46:467-74.
11. European Respiratory Society. Standardized lung function testing. Eur Respir J 1993;6(Suppl. 6).
12. Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 1984;39:535-8.
13. Verin E, Straus C, Demoule A, et al. Validation of improved recording site to measure phrenic conduction from surface electrodes in humans. J Appl Physiol 2002;92:967-74.
14. Green M, Road J, Sieck G, Similowski T. ATS/ERS Statement on respiratory muscle testing. Tests of respiratory muscle strength. Am J Respir Crit Care Med 2002;166:528-47.
15. Similowski T, Fleury B, Launois S, Cathala HP, Bouche P, Derenne JP. Cervical magnetic stimulation: a new painless method for bilateral phrenic nerve stimulation in conscious humans. J Appl Physiol 1989;67:1311-8.
16. Similowski T, Mehiri S, Attali V, Duguet A, Straus C, Derenne J-P. Comparison of magnetic and electrical phrenic nerve stimulation in assessment of phrenic nerve conduction time. J Appl Physiol 1997;82: 1190-9.
17. Laghi F, Tobin MJ. Relationship between transdiaphragmatic and mouth twitch pressures at functional residual capacity. Eur Respir J 1997;10:530-6.
18. Hamnegard CH, Wragg S, Kyroussis D, et al. Mouth pressure in response to magnetic stimulation of the phrenic nerves. Thorax 1995; 50:620-4.
19. Similowski T, Straus C, Attali V, Duguet A, Derenne JP. Cervical magnetic stimulation as a method to discriminate between diaphragm and rib cage muscle fatigue. J Appl Physiol 1998;84:1692-700.
20. Mador JM, Rodis A, Diaz J. Diaphragmatic fatigue following voluntary hyperpnea. Am J Respir Crit Care Med 1996;154:63-7.
21. Hamnegard CH, Wragg SD, Mills GH, et al. Clinical assessment of diaphragm strength by cervical magnetic stimulation of the phrenic nerves. Thorax 1996;51:1239-42.
22. Series F, Demoule A, Marc I, Sanfacon C, Derenne JP, Similowski T. Inspiratory flow dynamics during phrenic nerve stimulation in awake normals during nasal breathing. Am J Respir Crit Care Med 1999;160: 614-20.
23. Lakhanpal S, Lie JT, Conn DL, Martin 2nd WJ. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46:23-9.
24. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985;28:249-55.
25. Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988;18:29-37.
26. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-5.
27. Takase Y, Inoue K, Mannen T. Acute respiratory failure in polymyositis. J Neurol 1989;236:123-4.
28. Blanco S, Ayensa C, Agud J, Zubizarreta J. Paralisis de la musculatura respiratoria en la polimiositis. Tratamiento con pulsos de ciclofosfamida. [Paralysis of the respiratory muscles in polymyositis. Treatment with cyclophosphamide pulses]. Rev Clin Esp 1992;191:111-2.
29. Cohen R, Lipper S, Dantzker DR. Inclusion body myositis as a cause of respiratory failure. Chest 1993;104:975-7.
30. Sano M, Suzuki M, Sato M, Sakamoto T, Uchigata M. Fatal respiratory failure due to polymyositis. Intern Med 1994;33:185-7.
31. Astudillo LM, Carreiro M, Sailler L, Dingremont CF, Arlet PM. Hypercapnic coma due to diaphragmatic involvement in a patient with dermatomyositis. Clin Exp Rheumatol 2001;19:456-8.
32. Dauriat G, Stern J-B, Similowski T, et al. Acute respiratory failure due to diaphragmatic weakness revealing a polymyositis. Eur J Intern Med 2002;13:203-5.
33. Martin L, Chalmers IM, Dhingra S, McCarthy D, Hunter T. Measurements of maximum respiratory pressures in polymyositis and dermatomyositis. J Rheumatol 1985;12:104-7.
34. Hebert CA, Byrnes TJ, Baethge BA, Wolf RE, Kinasewitz GT. Exercise limitation in patients with polymyositis. Chest 1990;98: 352-7.
35. Braun NM, Arora NS, Rochester DF. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983;38:616-23.
36. Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984;14:60-76.
37. De Troyer A, Estenne M. Limitations of measurement of transdiaphragmatic pressure in detecting diaphragmatic weakness. Thorax 1981; 36:169-74.
38. Verin E, Delafosse C, Straus C, et al. Effects of muscle group recruitment on sniff transdiaphragmatic pressure and its components. Eur J Appl Physiol 2001;85:593-8.
39. Hughes PD, Polkey MI, Moxham J, Green M. Long-term recovery of diaphragm strength in neuralgic amyotrophy. Eur Respir J 1999;13: 379-84.
40. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994;150:11-16.